Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children

This publication has 61 references indexed in Scilit:

• Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in Infancy
  New England Journal of Medicine, 1987
• Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age
  The Journal of Pediatrics, 1987
• IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEIN
  The Lancet, 1986
• Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b
  The Journal of Pediatrics, 1985
• Specific antibodies to diphtheria toxin and type 6a pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen
  Molecular Immunology, 1985
• Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age
  The Journal of Pediatrics, 1985
• Immunogenicity of Haemophilus influenzae type b polysaccharide—diphtheria toxoid conjugate vaccine in adults
  The Journal of Pediatrics, 1984
• Correlation between Serum IgG-2 Concentrations and the Antibody Response to Bacterial Polysaccharide Antigens
  New England Journal of Medicine, 1980
• Interim Report of a Controlled Field Trial of Immunization with Capsular Polysaccharides of Haemophilus influenzae Type band Group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976)
  The Journal of Infectious Diseases, 1977
• Characterization of human antibody to polyribophosphate, the capsular antigen of hemophilus influenzae, type B
  Clinical Immunology and Immunopathology, 1973